| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Announcement
|
|
|
2007
|
139 |
3 |
p. 515
|
artikel
|
| 2 |
Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease
|
Shimada, Masako
|
|
2007
|
139 |
3 |
p. 458-463
|
artikel
|
| 3 |
Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status
|
Sheikholeslami, Mohammad Reza
|
|
2007
|
139 |
3 |
p. 507-509
|
artikel
|
| 4 |
Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres
|
Kuter, David J.
|
|
2007
|
139 |
3 |
p. 351-362
|
artikel
|
| 5 |
Book review
|
Stanworth, Dr Simon
|
|
2007
|
139 |
3 |
p. 514
|
artikel
|
| 6 |
Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine
|
Bacchu, S.
|
|
2007
|
139 |
3 |
p. 349
|
artikel
|
| 7 |
Ciclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity
|
Cataland, Spero R.
|
|
2007
|
139 |
3 |
p. 486-493
|
artikel
|
| 8 |
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma
|
Mann, Georg
|
|
2007
|
139 |
3 |
p. 443-449
|
artikel
|
| 9 |
Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene
|
Ma, Edmond S. K.
|
|
2007
|
139 |
3 |
p. 509-511
|
artikel
|
| 10 |
Fibrinogen γ′ chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway
|
Lovely, Rehana S.
|
|
2007
|
139 |
3 |
p. 494-503
|
artikel
|
| 11 |
Flexible and dynamic organization of bone marrow stromal compartment
|
Anjos-Afonso, Fernando
|
|
2007
|
139 |
3 |
p. 373-384
|
artikel
|
| 12 |
High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia
|
Troeger, Anja
|
|
2007
|
139 |
3 |
p. 450-457
|
artikel
|
| 13 |
Improvement of fibrosis in a patient with chronic myeloproliferative disease
|
Retter, Andrew
|
|
2007
|
139 |
3 |
p. 350
|
artikel
|
| 14 |
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults
|
van Heeckeren, Willem J.
|
|
2007
|
139 |
3 |
p. 464-474
|
artikel
|
| 15 |
Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP
|
Shen, Ming Y.
|
|
2007
|
139 |
3 |
p. 475-485
|
artikel
|
| 16 |
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis
|
Wu, Catherine J.
|
|
2007
|
139 |
3 |
p. 504-507
|
artikel
|
| 17 |
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
|
Curti, Antonio
|
|
2007
|
139 |
3 |
p. 415-424
|
artikel
|
| 18 |
Platelet glycoprotein VI-related clinical defects
|
Arthur, Jane F.
|
|
2007
|
139 |
3 |
p. 363-372
|
artikel
|
| 19 |
Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma
|
O'Connor, Owen A.
|
|
2007
|
139 |
3 |
p. 425-428
|
artikel
|
| 20 |
Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera
|
Scott, Linda M.
|
|
2007
|
139 |
3 |
p. 511-512
|
artikel
|
| 21 |
Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders
|
Steensma, David P.
|
|
2007
|
139 |
3 |
p. 439-442
|
artikel
|
| 22 |
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia
|
Maddocks-Christianson, Kami
|
|
2007
|
139 |
3 |
p. 398-404
|
artikel
|
| 23 |
RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
|
Chen, Chien-Yuan
|
|
2007
|
139 |
3 |
p. 405-414
|
artikel
|
| 24 |
Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease
|
Oyajobi, Babatunde O.
|
|
2007
|
139 |
3 |
p. 434-438
|
artikel
|
| 25 |
Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study
|
Feyler, Sylvia
|
|
2007
|
139 |
3 |
p. 429-433
|
artikel
|
| 26 |
The contribution of α2-macroglobulin thrombin to the endogenous thrombin potential
|
Hemker, H. C.
|
|
2007
|
139 |
3 |
p. 513
|
artikel
|
| 27 |
The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage
|
Feng, Rentian
|
|
2007
|
139 |
3 |
p. 385-397
|
artikel
|
Tijdschrift beschrijving